Adenovirus vector-based multi-epitope vaccine provides partial protection against H5, H7, and H9 avian influenza viruses.
The emergence of H5, H7, and H9 avian influenza virus subtypes in humans reveals their pandemic potential. Although human-to-human transmission has been limited, the genetic reassortment of the avian and human/porcine influenza viruses or mutations in some of the genes resulting in virus replication...
Main Authors: | Ahmed O Hassan, Omar Amen, Ekramy E Sayedahmed, Sai V Vemula, Samuel Amoah, Ian York, Shivaprakash Gangappa, Suryaprakash Sambhara, Suresh K Mittal |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5638338?pdf=render |
Similar Items
-
A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose
by: Ekramy E. Sayedahmed, et al.
Published: (2018-09-01) -
Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based H5N1 influenza vaccine.
by: Aseem Pandey, et al.
Published: (2012-01-01) -
Nasal delivery of H5N1 avian influenza vaccine formulated with GenJet™ or in vivo-jetPEI® induces enhanced serological, cellular and protective immune responses
by: Weiping Cao, et al.
Published: (2018-01-01) -
Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness.
by: Sai V Vemula, et al.
Published: (2013-01-01) -
Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
by: Ekramy E. Sayedahmed, et al.
Published: (2020-10-01)